In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

It’s a pill, not an injection, which will likely make it more attractive. Novo Nordisk itself has a new and improved drug under development. Amycretin saw some participants lose 22% of their ...

We recently compiled a list of the Billionaire Ken Fisher’s Top 10 High Growth Stock Picks. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...

Novo Nordisk is also developing an oral drug for obesity, amycretin, which also performed better than Wegovy in a phase 3 obesity trial and is in mid-stage development. New approval for Zepbound ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

and New York City. The $520 million Florida campus will focus on tech and business graduate programs with space for about 1,000 students. Vanderbilt is also expanding its Nashville campus with new ...

With a new baby and new jobs, a couple searched the city’s residential neighborhoods with ‘little idea of what the real Miami might be.’ Here’s what they found. By Debra Kamin Paying ...